PRTN3 and rheumatoid arthritis: The association of antibodies against cit-TNC17 and cit-TNC56 with the SE, smoking, and rheumatoid factor mirrors the characteristics described in ACPA+ subjects who go on to develop RA (3, 15, 35–41).